Skip to main content
. 2020 May 11;5:10. doi: 10.1038/s41536-020-0094-3

Fig. 1. Therapeutic workflow for muscle stem cells in regenerative medicine utilizing multiple convergent advances.

Fig. 1

(Left) Muscle stem cells (MuSCs) prospectively isolated from muscle tissue or derived from differentiation of induced pluripotent stem cells (iPSCs). (Middle) Ex vivo expansion of MuSCs in optimized culture platform that mimics in vivo microenvironment supporting self-renewal. (Right) Delivery of undifferentiated MuSCs into diseased/damaged muscle with biometric scaffold boosting transplantation efficiency.